Back

Antibody responses to SARS-CoV-2 variants LP.8.1, LF.7.1, NB.1.8.1, XFG and BA.3.2 following KP.2 monovalent mRNA vaccination

2025-08-27 infectious diseases Title + abstract only
View on medRxiv
Show abstract

The evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in antigenically distinct variants that challenge vaccine-induced immunity. The KP.2 monovalent mRNA vaccine was deployed in 2024 to address immune escape by emerging SARS-CoV-2 subvariants. We assessed neutralizing antibody responses in 56 adults with varied exposure histories following KP.2 vaccination against emerging variants including LP.8.1, LF.7.1, NB.1.8.1, XFG, and BA.3.2. While KP.2 vaccination e...

Predicted journal destinations

1
Nature Communications
483 training papers
Top 0.3% 28.2%
2
Clinical Infectious Diseases
219 training papers
Top 5% 5.9%
3
mBio
34 training papers
#1 5.9%
4
The Journal of Infectious Diseases
137 training papers
Top 2% 5.0%
5
Nature Medicine
88 training papers
Top 0.2% 5.0%
6
The Lancet Infectious Diseases
57 training papers
Top 0.5% 3.8%
7
Vaccine
140 training papers
Top 3% 3.8%
8
New England Journal of Medicine
49 training papers
Top 0.9% 2.7%
9
Cell
28 training papers
Top 0.5% 1.9%
10
Nature
58 training papers
Top 1% 1.9%
11
Science Translational Medicine
40 training papers
Top 0.7% 1.9%
12
Emerging Infectious Diseases
84 training papers
Top 8% 1.5%
13
Viruses
79 training papers
Top 4% 1.5%
14
JCI Insight
63 training papers
Top 4% 1.5%
15
Cell Reports Medicine
49 training papers
Top 3% 1.5%
16
Open Forum Infectious Diseases
124 training papers
Top 9% 1.5%
17
Science
46 training papers
Top 3% 1.3%
18
Frontiers in Immunology
140 training papers
Top 9% 1.3%
19
Vaccines
131 training papers
Top 8% 1.3%
20
Journal of Infection
64 training papers
Top 4% 1.3%
21
Scientific Reports
701 training papers
Top 90% 1.2%
22
BMC Medicine
155 training papers
Top 23% 1.2%
23
eLife
262 training papers
Top 45% 0.9%
24
eBioMedicine
82 training papers
Top 9% 0.9%
25
Nature Microbiology
21 training papers
Top 0.4% 0.9%
26
Cell Reports
25 training papers
Top 2% 0.9%
27
Eurosurveillance
77 training papers
Top 14% 0.7%
28
PLOS ONE
1737 training papers
Top 99% 0.7%
29
iScience
74 training papers
Top 13% 0.7%
30
npj Vaccines
18 training papers
Top 0.9% 0.7%